TICALIX®

Categories: Thrombolytics

Generic name: Rivaroxaban

Indications:

Patients with acute coronary syndrome (ACS) or a history of myocardial infarction
Patients with coronary artery disease (CAD) at high risk for ischemic events
Patients with acute ischemic stroke (NIHSS ≤5) or high-risk transient ischemic attack (TIA)
Ticalix® is produced at a GMP approved manufacturing site

View API Documentation Call Us

Product Sharing:

Apirax Apixaban Cardiovascular Neurology

Product Description:

Ticagrelor and its major metabolite reversibly interact with the platelet P2Y12 ADP-receptor to prevent signal transduction and platelet activation. Ticagrelor and its active metabolite are approximately equipotent

Additional Information

TICALIX®

Additional information

TICALIX®